Condition
Tissue Damage
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Completed3
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT03123458Phase 1Enrolling By Invitation
Clonal Fetal Mesenchymal Stem Cells (cfMSCs) for the Control of Immune-related Disorders
NCT03040921Not ApplicableCompleted
Uterine Transposition: Feasibility Study
NCT04896359Not ApplicableCompletedPrimary
High Doses Vitamin C and Tissular Repair in Surgical Patients
NCT04389047Completed
Comparison of Two Mechanical Ventilation Modes on Oxygenisation
Showing all 4 trials